AVNS Financial Overview

Comprehensive financial analysis and stock performance data for AVNS. This dashboard provides key metrics, financial ratios, and interactive charts to help you make informed investment decisions.

AVNS

Avanos Medical, Inc.

Healthcare

CEO: Ms. Mojirade James

IPO: 2014-10-21

2,227 employees

$15.30

0.28 (1.83%)

Market Cap

703.85M

Enterprise Value

766M

Revenue (TTM)

687.8M

Net Income

-392,100,000

P/E Ratio

-1.79x

ROE

-34.79%

Valuation Metrics

Market Cap

704M

Enterprise Value

766M

P/E Ratio

-1.79x

P/S Ratio

1.02x

P/B Ratio

0.85x

EV/Sales

1.11x

EV/FCF

9.24x

Earnings Yield

-55.71%

FCF Yield

11.78%

Price to Operating Cash Flow

6.99x

Gross Margin

55.44%

Margin Metrics

Operating Margin

-55.68%

Net Margin

-57.01%

Pretax Margin

-58.64%

ROIC

-36.37%

Dividends

Payout Ratio

0.00%

Dividend Yield

0.00%

Dividend per Share

$0.00

Return Metrics

ROE

-34.79%

ROCE

-38.75%

ROA

-33.97%

PEG Ratio

0.00x

Payout Ratio

0.00%

Financial Health

Debt to Assets

14.75%

Net Debt/EBITDA

-0.18x

Growth Metrics

3Y Revenue Growth

-1.15%

5Y Revenue Growth

0.40%

10Y Revenue Growth

-8.39%

3Y Net Income Growth

NaN%

5Y Net Income Growth

NaN%

10Y Net Income Growth

NaN%

3Y OCF Growth

6.45%

5Y OCF Growth

27.72%

10Y OCF Growth

-3.66%

Stock Performance

Interactive stock chart with historical price data and comparison tools. Analyze price movements, volume trends, and compare with other stocks or indices.

AVNS

AVNS·Total: -22.65%·CAGR: -22.65%